Huawei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huawei Wang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Yancheng Xu
Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
2 shared publications Beier Tong
Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
1 shared publicationGuangzhen He
Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
1 shared publicationGuijun Wu
Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
1 shared publication- Haibo Xu
Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan City, China
1 shared publication Jie Liu
Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
1 shared publication
Latest Publications
- 1 October 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (1) , e250026
Liver MRI–derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study
The liver MRI–derived proton density fat fraction (PDFF) independently predicted prediabetes and diabetes risk in patients with obesity, and the liver PDFF–dysglycemia relationship was partially mediated by liver enzymes.
- 1 October 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (1) , e250026
Liver MRI–derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study
The liver MRI–derived proton density fat fraction (PDFF) independently predicted prediabetes and diabetes risk in patients with obesity, and the liver PDFF–dysglycemia relationship was partially mediated by liver enzymes.
- Open Access
- 1 December 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 120, 109503
Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage
- 1 December 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 120, 109503
Open AccessNr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage
- 1 December 2018
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 64, 112-121
Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress
- 1 December 2018
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 64, 112-121
Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress